Dex-Moxi-Ketor
Approved
Approval ID
62fff769-95d6-0908-e053-2a91aa0a732d
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 10, 2020
Manufacturers
FDA
Imprimis NJOF, LLC
DUNS: 080431967
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Dexamethasone Phosphate - Moxifloxacin - Ketorolac Tromethamine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71384-513
Product Classification
G
Generic Name
Dexamethasone Phosphate - Moxifloxacin - Ketorolac Tromethamine
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateFebruary 10, 2020
FDA Product Classification
INGREDIENTS (3)
DEXAMETHASONE SODIUM PHOSPHATEActive
Quantity: 1 mg in 1 mL
Code: AI9376Y64P
Classification: ACTIR
KETOROLAC TROMETHAMINEActive
Quantity: 0.4 mg in 1 mL
Code: 4EVE5946BQ
Classification: ACTIM
MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATEActive
Quantity: 0.5 mg in 1 mL
Code: B8956S8609
Classification: ACTIM